MOFICEPT 500MG TABLET

Moficept  500mg tablet is an immune suppressant with an active ingredient named Mycophenolate mofetil. It is part of the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop organ rejection in patients who have received one of their organs (such as heart, kidney, and liver transplants). It is often prescribed as part of a combination treatment, which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It is not recommended for pregnant women unless there are other alternatives and the benefits outweigh any risks. Women who are born are strongly advised to take effective contraception when taking this tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered while a patient is taking Moficept 500 mg Tablet due to the reduced effectiveness and risk of contracting infection. Patients taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures that the drug has been completely removed from the body before giving blood.
It is recommended not to take this drug if you have an allergy to the drug or other ingredients. Inform your doctor about heart or liver problems before starting the treatment. Since this medication weakens the body’s immune system, it increases the risk of developing skin cancer. Patients must know how to minimize their exposure to the ultraviolet (UV) ultraviolet (UV) light. Consult your physician immediately if you experience any bleeding on your face, fever, or other unintentional fatigue, dizziness, eyes, or skin. Eyes vision impairment, decreased urinary output, or seizures following the use of this medication. Moficept 500 mg Tablet is an anti-inflammatory medication. It can affect the infant’s developing immune system, so it is recommended to avoid it while breastfeeding. In some instances, alternatives to drugs that have an improved safety profile when breastfeeding could be thought of as.